CI logo

The Cigna Group Stock Price

NYSE:CI Community·US$74.9b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 105 Fair Values set on narratives written by author

CI Share Price Performance

US$0
-317.09 (-100.00%)
US$339.58
Fair Value
US$0
-317.09 (-100.00%)
Price US$0

CI Community Narratives

·
Fair Value US$339.58 17.0% undervalued intrinsic discount

CI: Share Repurchase Momentum Will Drive Long-Term Shareholder Value Creation

1users have liked this narrative
0users have commented on this narrative
52users have followed this narrative
US$339.58
17.0% undervalued intrinsic discount
Revenue
4.12% p.a.
Profit Margin
2.48%
Future PE
13.48x
Price in 2029
US$414.55

Trending Discussion

Updated Narratives

CI logo

CI: Leadership Transition And Buybacks Will Support Future Share Upside

Fair Value: US$339.58 17.0% undervalued intrinsic discount
52 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Very undervalued established dividend payer.

1 Risk
6 Rewards

The Cigna Group Key Details

US$277.9b

Revenue

US$252.5b

Cost of Revenue

US$25.4b

Gross Profit

US$19.1b

Other Expenses

US$6.3b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Jul 30, 2026
23.77
9.15%
2.26%
72.8%
View Full Analysis

About CI

Founded
1792
Employees
66685
CEO
David Cordani
WebsiteView website
www.thecignagroup.com

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Recent CI News & Updates

Seeking Alpha May 18

Cigna: Shares Marching To Full Recovery

Summary Cigna Group is reiterated as a "Buy," driven by strong Q1 2026 results, raised guidance, and sustained business momentum. CI’s pharmacy and behavioral health segments are fueling revenue growth, while divestitures and PBM reform temporarily temper 2026 earnings. Shares trade at a 25% discount to a $377 fair value estimate, offering potential 15% annual total returns through 2031. Cigna’s robust balance sheet, market-leading dividend coverage, and growth catalysts in biosimilars and behavioral health underpin the investment thesis. Read the full article on Seeking Alpha

Recent updates

No updates